Carvacrol Attenuated Neuroinflammation, Oxidative Stress and Depression and Anxiety Like Behaviors in Lipopolysaccharide-challenged Rats
Overview
Authors
Affiliations
Objective: The beneficial effect of carvacrol on neuroinflammation, oxidative damage of brain tissue, and depressive- and anxiety-like behaviors after lipopolysaccharide (LPS) administration were evaluated in rats.
Materials And Methods: Vehicle (1% Tween 80), 1 mg/kg of LPS, and carvacrol (25, 50, or 100 mg/kg administered prior to LPS) were injected and behavioral and biochemical tests were done.
Results: The results of forced swim test revealed that carvacrol attenuated immobility time and increased activity and climbing times (p<0.05 to p<0.001). The results of elevated plus maze also revealed that treatment by carvacrol prolonged the open arms time and entries and decreased the time and entries in the closed arms (p<0.05 to p<0.01). Carvacrol enhanced crossing, time, and traveled distance in the central segment of the open field and increased total crossing and distance while attenuating the peripheral zone time (p<0.05 to p<0.001). All doses of carvacrol attenuated TNF- α (tumor necrosis factor α) and NO (nitric oxide) in the brain (p<0.01 to p<0.001). The 50 and the 100 mg/kg doses of carvacrol decreased malondialdehyde (p<0.001 for both), and the 100 mg/kg dose of carvacrol increased the content of the thiol (p<0.001).
Conclusion: In conclusion, carvacrol improved the behavioral consequences of LPS challenge and attenuated neuroinflammation and brain tissue oxidative stress in rats.
Anaeigoudari A Food Sci Nutr. 2025; 13(2):e70026.
PMID: 39898124 PMC: 11786020. DOI: 10.1002/fsn3.70026.
Tareen F, Catenacci L, Perteghella S, Sorrenti M, Bonferoni M Molecules. 2025; 30(1.
PMID: 39795159 PMC: 11721141. DOI: 10.3390/molecules30010104.
Arab Z, Salmani H, Marefati N, Beheshti F, Anaeigoudari A, Shakeri F Avicenna J Phytomed. 2023; 13(5):531-540.
PMID: 38089417 PMC: 10711579. DOI: 10.22038/AJP.2023.21914.
Hosseini M, Arab Z, Beheshti F, Anaeigoudari A, Shakeri F, Rajabian A Animal Model Exp Med. 2023; 6(3):221-229.
PMID: 37272426 PMC: 10272902. DOI: 10.1002/ame2.12323.
Cerrah S, Ozcicek F, Gundogdu B, Cicek B, Coban T, Suleyman B Front Pharmacol. 2023; 14:1161448.
PMID: 37089925 PMC: 10113504. DOI: 10.3389/fphar.2023.1161448.